Loading...
  • ASCT
  • A recent shortage of melphalan has prompted the use of alternatives to BEAM (BCNU, Etoposide, Cytarabine, Melphalan) conditioning for autologous stem cell transplantion (ASCT). (bioportfolio.com)
  • Phase
  • Because one patient (UPN11) received extra medication during the conditioning phase due to rapid disease progression, the patient was considered as evaluable only for engraftment. (bloodjournal.org)
  • blood
  • http://www.medisteminc.com ), reported positive safety data in 114 patients who were treated by doctors at Nanshan Affiliated Hospital of Guangdong Medical College (Shenzhen Nanshan Hospital) in Shenzhen using Beike's proprietary cord blood stem cell transplantation protocol. (news-medical.net)
  • However, it also suggests cord-blood-derived stem cells are a safe and viable treatment option for a much broader range of diseases and conditions than previously thought. (news-medical.net)
  • During surgery a flow monitor is used to monitor the blood flow into the kidney immediately after transplantation. (isrctn.com)
  • participants
  • Study researchers will keep track of the patient's medical condition after leaving the transplant center by phone calls or mailings to patients and their doctors once a year for the rest of the study participants' lives. (clinicaltrials.gov)
  • After transplantation participants receive the normal treatment and care associated with receiving a kidney transplant and the surgery will not be altered in any way, regardless of the group that the patient is in. (isrctn.com)
  • Participants are also required to attend the normal clinic visits at weekly intervals for the first month after transplantation, then at 1, 2 and 3 months for routine patient assessment. (isrctn.com)
  • Participants will experience no additional effects to their lifestyles, other than that which is expected following transplantation. (isrctn.com)
  • Years
  • Subgroup analyses showed that patients aged between 40 and 49 years as well as those in first or second CR at the time of transplantation exhibited similar outcomes regardless of whether they were treated with RIC or MAC. (ovid.com)
  • Similarly, CD4 + CD45RA + (na├»ve) T-cell counts increased from day 100 to one and two years after transplantation in patients aged 50 years and under 50 ( P =0.002 and P =0.02, respectively), and in those aged 51-60 ( P =0.4 and P =0.001, respectively), but less so in patients aged over 60 ( P =0.3 and P =0.06, respectively). (haematologica.org)
  • research
  • Some drugs and medical devices described on this Site have Food and Drug Administration (FDA) clearance for limited use in restricted research settings and to treat only specifically approved medical conditions. (lww.com)
  • improve
  • The aim of this study is to find out whether a technique called remote postconditioning (RPC) can improve the function of the kidney after transplantation. (isrctn.com)